-
Mashup Score: 0EA3202 Home Page - ECOG-ACRIN Cancer Research Group - 7 month(s) ago
Patient must have histologically confirmed squamous cell carcinoma of the head and neck (HNSCC) (excluding SCC of salivary glands, Epstein-Barr virus [EBV]-associated nasopharynx and skin)Patient must have measurable disease as defined by Response Evaluation Criteria in Solid Tumors (RECIST) version (v)1.1. Measurements must be obtained within 4 weeks prior to randomizationPatient must be >= 18…
Source: ECOG-ACRIN Cancer Research GroupCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2EA4151 Home Page - ECOG-ACRIN Cancer Research Group - 8 month(s) ago
United StatesAKAnchorageAlaska Breast Care and Surgery LLCContact: Site Public ContactEmail: AKPAMC.OncologyResearchSupport@providence.orgAlaska Oncology and Hematology LLCContact: Site Public ContactEmail: AKPAMC.OncologyResearchSupport@providence.orgAlaska Women’s Cancer CareContact: Site Public ContactEmail: AKPAMC.OncologyResearchSupport@providence.orgAnchorage Associates in Radiation…
Source: ECOG-ACRIN Cancer Research GroupCategories: Hem/Oncs, Latest HeadlinesTweet-
@rosslevinemd @DrChrisHourigan We are hoping ECOG4151 will change this in mantle cell lymphoma. Close to accrual and will be nearly 700 pts, randomized transplant vs no transplant in the MRD neg pts https://t.co/lZh1W1Wdva
-
-
Mashup Score: 0Edith Peterson Mitchell, MD Health Equity Travel Scholarship - ECOG-ACRIN Cancer Research Group - 9 month(s) ago
Announcement: Applications are now being accepted for travel scholarships to attend the Fall 2023 Group Meeting from October 25-27 in Washington, DC. The deadline to apply is Monday, August 21, 2023, at 11:59 PM (Eastern Time). See below or download the announcement to learn more and apply. The ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) offers the Edith Peterson Mitchell, MD Health Equity…
Source: ECOG-ACRIN Cancer Research GroupCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Applications are open for the @eaonc Edith Peterson Mitchell, MD Health Equity Travel Scholarship for medical and research trainees to attend the Fall 2023 Group Meeting. Learn more or apply: https://t.co/cJfg763Vrz
-
-
Mashup Score: 3
A new precision medicine initiative to test new combinations of cancer drugs guided by tumor biology
Source: ECOG-ACRIN Cancer Research GroupCategories: Hem/Oncs, Latest HeadlinesTweet-
Thrilled for @capitalhealthnj to participate in ComboMATCH: investigators are translating robust pre-clinical evidence for new anti-cancer drug combinations into a series of early-phase clinical trials https://t.co/w8B3APDLRs #clinicaltrial #CancerResearch #CancerMoonshot https://t.co/4EaW6DcdNh
-
-
Mashup Score: 0EAA173 / DETER-SMM Home Page - ECOG-ACRIN Cancer Research Group - 1 year(s) ago
United StatesAKAnchorageAlaska Breast Care and Surgery LLCContact: Site Public ContactEmail: AKPAMC.OncologyResearchSupport@providence.orgAlaska Oncology and Hematology LLCContact: Site Public ContactEmail: AKPAMC.OncologyResearchSupport@providence.orgAlaska Women’s Cancer CareContact: Site Public ContactEmail: AKPAMC.OncologyResearchSupport@providence.orgAnchorage Associates in Radiation…
Source: ECOG-ACRIN Cancer Research GroupCategories: Expert Picks, Latest HeadlinesTweet-
This wise thread will imply that the ongoing ecog study is useless, which I agree with The control arm should have been observation https://t.co/PO6XRdA7YW https://t.co/lPFcb0f8Iu
-
-
Mashup Score: 0Minority Travel Scholarships - ECOG-ACRIN Cancer Research Group - 1 year(s) ago
Call for applications to attend the Spring 2023 Group Meeting, May 3-5, 2023: Download Here The ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) offers travel scholarships to encourage minority investigator trainees and minority research-focused trainees to attend the group meetings, which occur twice a year in the spring and fall. The meeting features a Health Equity Committee Plenary Session and…
Source: ECOG-ACRIN Cancer Research GroupCategories: Hem/Oncs, Latest HeadlinesTweet-
. @eaonc is offering travel award scholarships to underrepresented minority & minority research-focused trainees and early career investigators to attend our Spring 2023 Meeting. This is a great meeting for those interested in clinical trials. apply here https://t.co/DFyDQZ88vn
-
-
Mashup Score: 7EAQ202 Home Page - ECOG-ACRIN Cancer Research Group - 1 year(s) ago
United StatesAKFairbanksFairbanks Memorial HospitalContact: Site Public ContactEmail: Veronica.Stevenson@foundationhealth.orgARFt. SmithMercy Hospital Fort SmithContact: Site Public ContactHot SpringsCHI Saint Vincent Cancer Center Hot SpringsContact: Site Public ContactEmail: ResearchInstituteInquiries@CommonSpirit.orgAZKingmanKingman Regional Medical CenterContact: Site Public ContactEmail:…
Source: ECOG-ACRIN Cancer Research GroupCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
If you know adolescents and young adults with cancer willing to help shape doctors' understanding of their needs, please share this trial. https://t.co/0YQFJQRPUo #AYACSM #ChildhoodCancer
-
-
Mashup Score: 2Press Release: Practice-changing trial results for acute lymphoblastic leukemia (ALL) - 1 year(s) ago
Two treatments are still available in the NCI-MATCH precision medicine cancer trial while all other arms are now closed to enrollment.
Source: ECOG-ACRIN Cancer Research GroupCategories: Hem/Oncs, Latest HeadlinesTweet-
Press Release: Practice-changing trial results for acute lymphoblastic leukemia (ALL) #ASH22 @eaonc #leusm https://t.co/CnoAeQutxi
-
-
Mashup Score: 1E2211: Dr. Pamela Kunz discusses the trial results and talks about the challenges of managing endocrine tumors - 2 year(s) ago
Patients with advanced progressive pancreatic neuroendocrine tumors (NETs) have few treatment options. The E2211 randomized phase II trial shows the most prolonged progression-free survival reported for patients with these tumors. Recently, study chair Pamela L. Kunz, MD (Yale University School of Medicine), described the challenges of treating patients with pancreatic NETS.
Source: ECOG-ACRIN Cancer Research GroupCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
RT @eaonc: ICYMI, @PamelaKunzMD interview by @VJOncology #pancsm https://t.co/MLud8VKL3s
-
-
Mashup Score: 3
TMIST sites are effectively reaching women in their communities to gain a study population able to provide needed data to move breast cancer screening forward
Source: ECOG-ACRIN Cancer Research GroupCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
The Tomosynthesis Mammographic Imaging Screening Trial (#TMIST4BC) is more than halfway to its goal of 129K participants with more than 20% of women in the U S being Black. Including women from diverse backgrounds ensures results will be applicable to all https://t.co/Rkk8pQSdp9 https://t.co/MbvQacajLs
-
#ClinicalTrial EA3202, led by @AartiBhatiaMD of @YaleCancer, aims to improve results for patients with advanced-stage #HeadAndNeckCancer by comparing several treatment approaches. Learn more: https://t.co/IHBhEYp1Fo #HNCA #HNCASM https://t.co/SRxfYpuZ2Q